CLINICAL_TRIALS
trial_result
· 2018-11-23
Clinical Trial Update: E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma [Phase 1]
Summary
Phase 1 trial update for E7777 in patients with Peripheral T-Cell Lymphoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Co., Ltd. | Conditions: Peripheral T-Cell Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2018-11-23